Skip to main content
CE

Celularity

Florham Park, United States
Last funding
$10.0M
Post-IPO DebtSep 2026

Celularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies.

Backed byAlumni VenturesS32Human LongevityHeritage GroupUnited Therapeutics

About Celularity

How much funding has Celularity raised?

Celularity has raised $10.0M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in September 2026.

Who are Celularity's investors?

Celularity's investors include Alumni Ventures, S32, Human Longevity, Heritage Group, United Therapeutics.

Where is Celularity headquartered?

Celularity is headquartered in Florham Park, United States.

What does Celularity do?

Celularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies.

What stage is Celularity at?

Celularity is at the Post-IPO Debt stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Celularity — Funding & Investors." VCBacked, September 24, 2026, https://www.vcbacked.co/company/celularity. Accessed November 16, 2026.
APA
VCBacked. (2026). Celularity — Funding & Investors. Retrieved November 16, 2026, from https://www.vcbacked.co/company/celularity
Wikipedia (cite web)
{{cite web |title=Celularity — Funding & Investors |url=https://www.vcbacked.co/company/celularity |website=VCBacked |access-date=November 16, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at Celularity? Request a listing update

Founder contacts
m***@celularity.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →